Greenwich LifeSciences reports 80% recurrence reduction in cancer trial Dec 15, 2025 06:01AM
Greenwich LifeSciences Announces Preliminary Analysis Showing 80% Recurrence Rate Reduction in the Open Label Arm of FLAMINGO-01 Dec 15, 2025 06:00AM